TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reduction in fat‐soluble vitamin deficiencies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completion of screening test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discussion of screening with provider
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of screening tests ordered
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients achieving asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceptions of vigor
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Contrast-associated nephropathy (CAN)
Endpoint domain: Adverse events/effects
Primary endpoint: Composite end point inhospital
Endpoint domain: Adverse events/effects
Primary endpoint: Composite end point at 9 months
Endpoint domain: Adverse events/effects
Primary endpoint: Knowledge of hepatitis B and vaccination
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Renal failure development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Decrease in serum creatinine concentration and urinary protein excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean Numerical Rating Scale (NRS) pain score within 12 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay (LOS) in days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percentage of patients using opioids during the first 24 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality associated with serum 25(OH)D concentrations
Endpoint domain: Mortality/survival
Primary endpoint: Clinical malaria diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Confirmed malaria diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical dryness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Postexercise plasma creatine kinase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postexercise serum myoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean index scores of patient-reported symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: systolic and diastolic supine blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: upper body strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma phospholipid Docosahexaenoic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma phospholipid Arachidonic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under the curve of total bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family needs
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: I-123 MIBG washout rate from the myocardium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart-to-mediastinum ratio of I-123 MIBG uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survival (SURV)
Endpoint domain: Mortality/survival
Primary endpoint: brain activation indicative of increased cognitive control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: attention and visual processing in response to high-calorie food cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Primary hospitalization rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mood response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma big-endothelin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endothelin-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acknowledgment of report alerts
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: IBS-QOL score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Activity impairment reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HbA(1c) value <7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Heartburn-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regurgitation-free rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete symptom resolution rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Length-for-Age Z-score (LAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Infarct size on cardiac magnetic resonance imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Echocardiography results at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TIMI myocardial perfusion grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean percentage of mineralized bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' experiences
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean increase in pVO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean energy expended
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility and transfer ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delineation of layers of the esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: subjective sensations of hunger
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: CU-Q2oL scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: angioedema-burdened days/week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first recurrence of angioedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angiographic in-segment late loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite major adverse cardiac events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total hospital costs
Endpoint domain: Resource use
Primary endpoint: N200 latency and P300 amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Freedom from atrial arrhythmias
Endpoint domain: Mortality/survival
Primary endpoint: Pulmonary vein reconnection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total pain relief (TOTPAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma intact PTH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Gastrointestinal bleeding requiring transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Ductal closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of transient oliguria
Endpoint domain: Adverse events/effects
Primary endpoint: Prolonged compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-lab bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Mean hematoma size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: preeclampsia rates
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of prosthetic dislocation
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of recurrent prosthetic dislocations
Endpoint domain: Adverse events/effects
Primary endpoint: Need for further open surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time for anvil insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Operation cost
Endpoint domain: Resource use
Primary endpoint: HbA1c score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of stunting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 15-year original prosthesis cumulative survival rate
Endpoint domain: Mortality/survival
Primary endpoint: average 15-year bone loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fewer absences attributable to asthma
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Decline in daytime symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher scores on asthma management index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of advance care directives
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: daily OFF time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total ON time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite endpoint of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalisation for angina
Endpoint domain: Mortality/survival
Primary endpoint: Change in seated trough cuff SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients achieving BP goal (<140/90 mm Hg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increased parasympathetic tone (NN50 and pNN50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS reduction (analgesia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased noxious tolerance (EPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Purchases of healthier meal options
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of Life in Epilepsy (QOLIE)‐31 improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life in Epilepsy (QOLIE)‐89 improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Alanine aminotransferase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: fracture rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ED(50) for spinal ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ED(95) for spinal ropivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cross-sectional area of the femoral anteromedial tunnel aperture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Position of the AM graft center from the center of the tunnel aperture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Position of the PL graft center from the center of the tunnel aperture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total FIQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean time to treatment failure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Progression on the ALS Health State scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average time of defecation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fatigue indices improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: AIMS2 health status components
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient's assessment of disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laitinen Modified Questionnaire Indicators of Pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IRLS sum score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of systolic daytime ABPM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Establishing rapport
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Listing psychosocial history items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative radiation emitted
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin conductance responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of perforation closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum apolipoprotein AI (ApoAI) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total composite QMT z‐score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MMT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: timed motor tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of clinical symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: control of epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: resolution of hydrocephalus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: self-care behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom frequency and symptom distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular death, MI, cardiogenic shock, or heart failure
Endpoint domain: Mortality/survival
Primary endpoint: Stroke at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: urge and craving to smoke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma FFA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Paclitaxel concentrations in tumor periphery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Variability in marker concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak anaerobic power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients cancer-free
Endpoint domain: Mortality/survival
Primary endpoint: Maternal spirometric respiratory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Confidence in giving nutrition advice
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fewer disability days
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: fewer days off work
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: amount of hMG required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of embryos obtained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Future uncertainty
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: High-grade thrombopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Thromboembolic event
Endpoint domain: Adverse events/effects
Primary endpoint: Block efficacy in radial nerve distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain intensity on movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normalized APC sensitivity ratios (nAPCsr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Geometric mean concentrations (GMCs) of pneumococcal antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of subjects with post‐third dose titer > or =0.15 microg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of infants with post‐third dose titer > or =1.0 microg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total Liver Volume (TLV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA expression of epidermal barrier differentiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRNA expression of lipid measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of epidermal hyperplasia markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milk bacterial counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Back pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Smoking behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total amount of analgesic consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: linear analogue pain scores after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: times taken to regain ambulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: times taken to regain micturition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Documented advance directives discussions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VCAM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean right ventricular ejection fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clearance of cutaneous lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: prevalence of SIBO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nitro-glycerine stopping or alleviation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Exercise parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischaemic activity during daily activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in dyspnea score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PEFR at 10 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PEFR at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return visits to the ED
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: post-treatment outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: poor outcome (fatal stroke, disabling stroke, myocardial infarction, death from any cause)
Endpoint domain: Mortality/survival
Primary endpoint: Distribution of trichotomized BI scores at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lysholm function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion rate from SVT to sinus rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median cumulative 48-hour morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Equilibration time between central and effect compartment (T(1/2)ke0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC(50) of rocuronium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED(50) of rocuronium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental recovery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: SF-MPQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graft failure or complete occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: String sign
Endpoint domain: Adverse events/effects
Primary endpoint: Mean plasma nicotine concentration (AUC(10 min))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes